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Abstract: 
Recently the FDA has increased restrictions making it very difficult to get a new drug out. Therefore it is 
desirable to repurpose a drug already in use, one which has passed clinical studies and has few side 
effects. For this reason we created a method to repurpose existing drugs to treat diseases other than 
their known targets. In this study we chose to demonstrate our method on colorectal cancer. CRC is an 
interesting disease for this approach, as known CRC chemotherapy drugs are ineffective in curing this 
kind of cancer. To find repurposed drugs for CRC we first use a structural algorithm to identify probable 
CRC gene targets for a specific set of in market cancer drugs.  After prioritizing these targets, the 
relationships between the gene targets and the potential drugs are validated and scored using 
Autodock. We can then identify which drugs have the greatest potential of being repurposed to treat 
CRC. It is our hope that this method will be able to aid in finding new treatments for diseases without 
the cost and risk of developing new drugs. 
 
 
 
